The plasma level of retinol, vitamins A, C and α-tocopherol could reduce breast cancer risk? A meta-analysis and meta-regression
- 673 Downloads
Plasma antioxidants are supposed to be directly related to breast cancer risk. However, the results remain inconsistent. Herein, we carried this meta-analysis to comprehensively summarize the associations between plasma retinol, vitamins A, C and α-tocopherol and breast cancer risk.
We searched PubMed, Embase and the Cochrane Databases (through September 24, 2014) and the reference lists of the retrieved articles in English with sufficient information to estimate relative risk or odds ratio and the 95 % confidence intervals (CIs), or with mean serum/plasma level of vitamins and SD/SEM/p value in breast cancer and controls. Two reviewers independently extracted data using a standardized form, with any discrepancy adjudicated by the third reviewer.
Forty studies entered this meta-analysis. For the pooled OR, no significant association between plasma retinol and breast cancer was observed (p = 0.13). Significant association was observed between plasma α-tocopherol and breast cancer (pooled OR 0.42, 95 % CI 0.25, 0.72, p = 0.00) in the subgroup with the median lowest level of 5.74–9.16 μmol/L. For the weighted mean difference (WMD), the plasma α-tocopherol and vitamin C level between breast cancer and controls were significantly different [WMD = −0.93 μmol/L (95 % CI −1.26, −0.61, p = 0.00) and −2.51 μmol/L (95 % CI −4.00, −1.02, p = 0.00), respectively]. No significant association between plasma retinol and vitamin A and breast cancer was observed.
Severe α-tocopherol deficiency could increase breast cancer risk. The association between plasma vitamin C and breast cancer was only significant in case–control studies. There was no significant association between other vitamins and breast cancer risk.
KeywordsRetinol Vitamin A Vitamin C α-Tocopherol Breast cancer Meta-analysis
Thanks for the grants from the National Natural Science Foundation of China (No. 81172743).
Conflict of interest
All the authors declare that we have no potential conflict of interest.
- Aghvami T, Djalali M, Keshavarz A, Sadeghi MR, Zeraati H, Sadrzadeh Yeganeh H, Negahdar M (2006) Plasma level of antioxidant vitamins and lipid peroxidation in breast cancer patients. Iran J Public Health 35:42–47Google Scholar
- Al-Saleh I, Al-Doush I (2002) Serum selenium and dl-(alpha)-tocopherol levels in women with breast cancer. Trace Elem Electrolytes 19:118–124Google Scholar
- Deharveng G, Charrondiere UR, Slimani N, Southgate DA, Riboli E (1999) Comparison of nutrients in the food composition tables available in the nine European countries participating in EPIC. European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr 53:60–79CrossRefPubMedGoogle Scholar
- Dorgan JF, Sowell A, Swanson CA, Potischman N, Miller R, Schussler N, Stephenson HE Jr (1998) Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes Control 9:89–97CrossRefPubMedGoogle Scholar
- Hou MF et al (1998) Serum vitamin A level in breast cancer patients Kaohsiung. J Med Sci 14:673–678Google Scholar
- McPherson RAPM (2011) Henry’s clinical diagnosis and management by laboratory methods, 22nd edn. Elsevier Saunders, PhiladelphiaGoogle Scholar
- Ullah MF, Khan HY, Zubair H, Shamim U, Hadi SM (2011) The antioxidant ascorbic acid mobilizes nuclear copper leading to a prooxidant breakage of cellular DNA: implications for chemotherapeutic action against cancer. Cancer Chemother Pharmacol 67:103–110. doi: 10.1007/s00280-010-1290-4 CrossRefPubMedGoogle Scholar
- WHO (2011(WHO/NMH/NHD/MNM/11.3)) Serum retinol concentrations for determining the prevalence of vitamin A deficiency in populations Vitamin and Mineral Nutrition Information System. World Health Organization, GenevaGoogle Scholar